Hungary Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Hungary Pharmaceuticals and Healthcare Report Q3 2013 Jun 19th 2013, 00:00 BMI View: Our projections for Hungary’s pharmaceutical market continue to reflect the government’s ongoing structural reform programme, including measures that aim to control pharmaceutical prices and public expenditure on medicines. Therefore, we remain of the view that the Hungarian pharmaceutical market values will post a year-on-year contraction in 2013. As the market remains unattractive, large domestic drug producers will retain their focus on exports, further improving the country’s decidedly positive pharmaceutical trade balance over the coming years. Headline Expenditure Projections: ?? Pharmaceuticals: HUF610.97bn (US$2.72bn) in 2012 to HUF577.35bn (US$2.60bn) in 2013; -5.5% in local currency terms and -4.3% in US … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=103172. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/hungary-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions